CDEK by Data4ThePeople

Sign in Sign up

← All organizations

BHV Pharma

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 1, 2015

Acquired by Islet Sciences on Mar 13, 2014

Timeline

2010s

Jun 1, 2010
BHV Pharma— Founded
Mar 13, 2014
Islet Sciences— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

remogliflozin etabonate

Indications

Studied for

Recent trials (1)

NCT02537470Lead sponsorPhase 2Jul 1, 2015

Details

Founded: Raleigh, NC, US Jun 1, 2010
Last known activity: Jul 1, 2015